Prediction of Early Recanalization after Intravenous Thrombolysis in Patients with Large-Vessel Occlusion.

Authors:
Kim YD; Nam HS; Yoo J; Park H; Sohn SI and 26 more

Journal:
J Stroke

Publication Year: 2021

DOI:
10.5853/jos.2020.03622

PMCID:
PMC8189851

PMID:
34102759

Journal Information

Full Title: J Stroke

Abbreviation: J Stroke

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: The authors have no financial conflicts of interest."

Evidence found in paper:

"This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1A2A3074996); a faculty research grant of Yonsei University College of Medicine (6-2020-0202); and the “Dongwha” Faculty Research Assistance Program of Yonsei University College of Medicine (6-2019-0191)."

Evidence found in paper:

"For the validation cohort, we used data from the Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) registry (Clinicaltrials.gov: NCT02964052) []. The SECRET registry is a nationwide multicenter registry for exploring the selection criteria for patients who would benefit from reperfusion therapies. This study included 1,026 patients who had been registered retrospectively from 15 hospitals between January 2012 and December 2015 and 333 patients who had been registered prospectively from 13 hospitals between November 2016 and December 2017. There were 98 patients with visible thrombi in the distal ICA and/or MCA on initial thin-section NCCT and those with imaging data available before and after IV t-PA. However, there was an overlap of the study period between the Thrombus Imaging Study and the SECRET study. Therefore, we excluded 22 patients (anonymized) who were enrolled during the overlapped period. Finally, 76 patients were included for the validation (). This study was approved by the Institutional Review Board of each study hospital, and written informed consent was obtained from all patients enrolled prospectively."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025